Bank Julius Baer & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$212K Sell
448
-72
-14% -$36.2K ﹤0.01% 497
2025
Q4
$243K Buy
520
+390
+300% +$181K ﹤0.01% 471
2025
Q3
$55.5K Buy
130
+1
+0.8% +$388 ﹤0.01% 586
2025
Q2
$49.6K Sell
129
-1
-0.8% -$360 ﹤0.01% 547
2025
Q1
$44.9K Buy
130
+12
+10% +$3.86K ﹤0.01% 550
2024
Q4
$39K Sell
118
-8,009
-99% -$2.8M ﹤0.01% 576
2024
Q3
$3.92M Sell
8,127
-1,045
-11% -$383K 0.01% 238
2024
Q2
$3.28M Buy
+9,172
New +$2.98M 0.01% 197
2022
Q4
Sell
-236
Closed -$43K 587
2022
Q3
$43K Buy
236
+150
+174% +$29.9K ﹤0.01% 508
2022
Q2
$14K Buy
+86
New +$18.5K ﹤0.01% 572
2020
Q3
Sell
-20
Closed -$2K 753
2020
Q2
$2K Buy
+20
New +$2.08K ﹤0.01% 655

Other funds holding HCA

Bank Julius Baer & Co's HCA Position: Q1 2026 in Review

Bank Julius Baer & Co reduced its HCA Healthcare (HCA) stake by 14% in Q1 2026, selling an estimated $36.2K and leaving 448 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

Bank Julius Baer & Co first reported a position in HCA in Q2 2020 and has held it in 11 quarters since. The position peaked at $3.92M in Q3 2024. 1,418 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Bank Julius Baer & Co held 448 shares of HCA Healthcare worth $212K as of Q1 2026.
  • Bank Julius Baer & Co sold 72 HCA Healthcare shares in Q1 2026, an estimated $36.2K.
  • HCA Healthcare made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q1 2026, its #497 holding.
  • Bank Julius Baer & Co first reported a position in HCA Healthcare in Q2 2020 and has held it in 11 quarters since.
  • Bank Julius Baer & Co's HCA Healthcare position peaked at $3.92M in Q3 2024.
  • 1,418 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.